Sorcero, which makes AI agents for pharmaceutical companies to market new medications, raised a $42.5M Series B, bringing its total funding to $59M (Katherine Davis/Axios)
PositiveArtificial Intelligence

- Sorcero has raised $42.5 million in Series B funding, bringing its total funding to $59 million, as confirmed by CEO Dipanwita Das. This funding will enhance Sorcero's capabilities in creating AI agents for pharmaceutical marketing.
- The successful funding round signifies investor confidence in Sorcero's innovative approach to pharmaceutical marketing, which leverages AI technology to improve efficiency and effectiveness in the industry.
- This development reflects a broader trend in the tech sector, where companies like Numeric and Method Security are also securing significant funding, indicating a robust interest in AI
— via World Pulse Now AI Editorial System

